Michael Koby is a founding partner of 1315 Capital, a Philadelphia private-equity firm he co-founded. Organization, location and related investors we track.
Michael Koby is a founding partner of 1315 Capital, a Philadelphia private-equity firm he co-founded in 2014 with Adele Oliva. He previously led healthcare investing at Palm Ventures and worked at Galen Partners, Novoste, Medtronic, and Dillon, Read. The firm focuses on commercial-stage healthcare companies, including healthcare services, specialty pharmaceuticals, medical technology, outsourcing, and health and wellness. Its investments are primarily in growth-stage businesses, with a stated emphasis on companies capable of scaling revenue and pursuing acquisition or public-market outcomes. Reported investment sizes range from about $10 million to $30 million on average, while broader firm materials cite targets up to $40 million. Public materials do not clearly establish whether Koby typically leads or follows investments, although 1315 led Colorescience’s Series C round. Companies connected to Koby include Biocoat, CHC Solutions, Integration Health, JDS Therapeutics, Mosaic Diagnostics, and Onkos Surgical. His publicly stated investment view emphasizes specialized healthcare expertise and opportunity in smaller healthcare growth companies, including businesses with roughly $5 mi
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Philadelphia.
Investors like Michael Koby · Full investor directory · Investor access · Company funding database
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide